← All trials
NCT03544099
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2018
- Primary completion
- Jun 30, 2023
- Completion date
- Dec 31, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 63
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of TaiwanLead sponsor
- China Medical UniversityCollaborator
- Chang Gung UniversityCollaborator
- National Taiwan UniversityOverall official - principal investigator
- National Taiwan UniversityCollaborator
- Taichung Veterans General HospitalCollaborator
- Changhua Christian HospitalCollaborator
- National Cheng Kung UniversityCollaborator
- Sun Yat-Sen UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.